It is now well known that in AD brain several mitogenic pathways including those regulated by p21ras/MAP kinase are activated, leading to hyperphosphorylation of tau protein and for changes in βAPP metabolism and excessive Aβ liberation [52]. The gene discussed is MAPT; the disease is Alzheimer disease.